What is a potential risk when using Citrasate dialysate?

Citrasate dialysate contains citric acid and sodium citrate, which serve as a source of calcium and help to maintain the pH balance during the dialysis process. One of the primary functions of this dialysate is to act as an anticoagulant. However, it also poses specific risks, particularly regarding calcium levels in the blood.

When using Citrasate dialysate, patients may experience decreased levels of ionized calcium in the bloodstream, leading to hypocalcemia. This condition can have various impacts on the body, including muscle cramps, numbness, and potentially severe cardiac disturbances. Monitoring calcium levels is crucial when using this type of dialysate because the sodium citrate can sequester calcium, making it less available for essential physiological functions.

Understanding the implications of this anticoagulant mechanism and its association with calcium levels is vital for healthcare providers to manage and address potential risks effectively during treatment.